Teva Pharmaceutical Industries Ltd (TEVA) is higher by Thursday morning, with the stock gaining 0.85% in pre-market trading to 8.29. TEVA's short-term technical score of 82 indicates that the stock has traded more bullishly over the last month than 82% of stocks on the market. In the Drug Manufacturers - Specialty & Generic industry, which ranks 135 out of 146 industries, the stock ranks higher than 89% of stocks. Teva Pharmaceutical Industries Ltd has fallen 19.09% over the past month, closing at $9.89 on August 25. During this period of time, the stock fell as low as $8.22 and as high as $10.04. TEVA has an average analyst recommendation of Buy. The company has an average price target of $10.75.
TEVA has an Overall Score of 61. Find out what this means to you and get the rest of the rankings on TEVA!